Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0X8ZS
|
|||
| Former ID |
DNC002821
|
|||
| Drug Name |
3-Methylphenylalanine
|
|||
| Synonyms |
5472-70-8; 2-Amino-3-(m-tolyl)propanoic acid; 2-amino-3-m-tolyl-propionic acid; 3-Methy-DL-Phenylalanine; DL-3-ME-PHE-OH; 2-amino-3-(3-methylphenyl)propanoic acid; 3-METHYLPHENYLALANINE; 3-Methylphe; NSC14793; AC1L5E1A; SCHEMBL42906; AC1Q5S51; ss-m-Tolyl-a-amino-propionsaure; CTK8E3667; KS-00000JHC; 3-METHYL-DL-PHENYLALANINE; MolPort-003-990-079; 2-amino-3-(m-tolyl)propionic acid; 2283-42-3; NSC29447; NSC-29447; NSC-14793; AKOS016843161; AKOS000174493; MCULE-1997175050; AM83420; AB21660; 2-AMINO-3-M-TOLYLPROPANOIC ACID
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C10H13NO2
|
|||
| Canonical SMILES |
CC1=CC(=CC=C1)CC(C(=O)O)N
|
|||
| InChI |
1S/C10H13NO2/c1-7-3-2-4-8(5-7)6-9(11)10(12)13/h2-5,9H,6,11H2,1H3,(H,12,13)/t9-/m0/s1
|
|||
| InChIKey |
JZRBSTONIYRNRI-VIFPVBQESA-N
|
|||
| CAS Number |
CAS 114926-37-3
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
78867, 89034, 5350410, 9379320, 15042012, 30428508, 50642556, 53796085, 91752796, 103131432, 104722916, 113478943, 117543442, 124758165, 125362836, 125362837, 125659533, 126694674, 126725142, 128350768, 140152182, 163118579, 163389224, 164847539, 165354231, 170512558, 172088237, 172911560, 180674426, 204414000, 219400440, 223655504, 226427486, 242077647, 242078128, 249841943, 251875876, 252041103, 252307099
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cathepsin B (CTSB) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Lysosome | |||
| Antigen processing and presentation | ||||
| NetPath Pathway | TCR Signaling Pathway | |||
| IL2 Signaling Pathway | ||||
| Reactome | Collagen degradation | |||
| Trafficking and processing of endosomal TLR | ||||
| Assembly of collagen fibrils and other multimeric structures | ||||
| MHC class II antigen presentation | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.